Australia markets closed

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
18.41+0.40 (+2.22%)
At close: 04:00PM EDT
18.38 -0.03 (-0.16%)
After hours: 07:45PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
16,289,000
15,845,000
14,925,000
15,879,000
16,658,000
Cost of revenue
8,227,000
8,200,000
7,952,000
8,284,000
8,933,000
Gross profit
8,062,000
7,645,000
6,973,000
7,594,000
7,726,000
Operating expenses
Research development
991,000
953,000
838,000
967,000
997,000
Selling general and administrative
3,573,000
3,498,000
3,445,000
3,528,000
3,671,000
Total operating expenses
4,564,000
4,451,000
4,283,000
4,495,000
4,668,000
Operating income or loss
3,498,000
3,194,000
2,690,000
3,099,000
3,058,000
Interest expense
992,000
1,029,000
930,000
891,000
901,000
Total other income/expenses net
-2,583,000
-2,723,000
-4,859,000
-1,480,000
-6,500,000
Income before tax
-142,000
-624,000
-3,163,000
658,000
-4,406,000
Income tax expense
606,000
-7,000
-643,000
211,000
-168,000
Income from continuing operations
-749,000
-615,000
-2,499,000
456,000
-4,100,000
Net income
-453,000
-559,000
-2,446,000
417,000
-3,990,000
Net income available to common shareholders
-453,000
-559,000
-2,446,000
417,000
-3,990,000
Basic EPS
-1.98
-0.50
-2.12
0.38
-3.64
Diluted EPS
-1.98
-0.50
-2.12
0.38
-3.64
Basic average shares
1,117,500
1,119,000
1,110,000
1,102,000
1,095,000
Diluted average shares
1,117,500
1,119,000
1,110,000
1,107,000
1,095,000